Skip to main content
. 2023 Feb 6;15(2):542. doi: 10.3390/pharmaceutics15020542
AUC area under the blood concentration-time profile curve
Bcrp breast cancer resistance protein
CLR renal clearance
Cmax peak blood concentration
DDI drug-drug interactions
FUR Furosemide
LC-MS/MS liquid chromatography-tandem mass spectrometry
NOV Novobiocin
OAT organic anion transporters
PK Pharmacokinetics